| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |